(1)
Emery, P.; McInnes, I.; Mease, P.; Schiff, M.; Pricop, L.; Shen, S.; Wang, Z.; Gaillez, C. Secukinumab Sustains Individual Clinical Responses Over Time in Patients With Psoriatic Arthritis: 2-Year Results from a Phase 3 Trial. J of Skin 2018, 2, S21.